A share price of Cassava Sciences Inc [SAVA] is currently trading at $2.94, up 1.73%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SAVA shares have gain 17.60% over the last week, with a monthly amount drifted -0.34%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cassava Sciences Inc [NASDAQ: SAVA] stock has seen the most recent analyst activity on November 26, 2024, when H.C. Wainwright downgraded its rating to a Neutral. Previously, H.C. Wainwright upgraded its rating to Buy on October 08, 2024, and kept the price target unchanged to $116. On July 01, 2024, downgrade downgraded it’s rating to Neutral. B. Riley Securities downgraded its rating to a Neutral but stick to its price target of $44 on November 16, 2022. Cantor Fitzgerald downgraded its rating to a Neutral but $100 remained the price target by the analyst firm on July 15, 2021. Maxim Group reiterated a Buy rating for this stock on July 07, 2021, and upped its price target to $190. In a note dated April 27, 2021, B. Riley Securities initiated an Buy rating and provided a target price of $78 on this stock.
Cassava Sciences Inc experienced fluctuations in its stock price throughout the past year between $2.23 and $42.20. Cassava Sciences Inc [NASDAQ: SAVA] shares were valued at $2.94 at the most recent close of the market.
Analyzing the SAVA fundamentals
Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -59.86%, Pretax Profit Margin comes in at -7.52%, and Net Profit Margin reading is -7.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.12 and Total Capital is -0.84.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.78 points at the first support level, and at 2.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.12, and for the 2nd resistance point, it is at 3.31.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cassava Sciences Inc [NASDAQ:SAVA] is 3.55. As well, the Quick Ratio is 3.55, while the Cash Ratio is 2.61.
Transactions by insiders
Recent insider trading involved Kupiec James William, Chief Medical Officer, that happened on Nov 29 ’24 when 4000.0 shares were sold. Chief Financial Officer, Schoen Eric completed a deal on Nov 29 ’24 to sell 59800.0 shares. Meanwhile, Chief Financial Officer Schoen Eric sold 2000.0 shares on Nov 29 ’24.
